NCT00000236已完成2 期
Buprenorphine Pharmacology Related to Addiction Treatment
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
- 主要终点
- Drug use
研究概览
简要总结
The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Drug use
Opioid agonist effects
Opiate withdrawal
Psychological changes in: pupil diameter, blood pressure, heart rate, respiration
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Naltrexone and Bupropion Combination on Obese,Smoking Patients With SchizophreniaObeseCigarette-smokingSchizophreniaNCT02736474Shanghai Mental Health Center22
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3Heroin DependenceOpioid-Related DisordersNCT00000328University of Colorado, Denver
已完成
1 期
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4Opioid-Related DisordersSubstance-Related DisordersNCT00000355National Institute on Drug Abuse (NIDA)
招募中
2 期
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use DisorderOpioid-use DisorderNCT05011266New York State Psychiatric Institute180